Follow the Arcadia Biosciences, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.4m. The latest transaction was disclosed on 5 February 2025 (Acquisition). Among the most active insiders: Schaefer Thomas J.. All data is free.
13
Insider Decl.
n/a
Thresholds
€30,289
9 ops.
Buy Volume
n/a
3 ops.
Sell Volume
44Σ signal
Buys €30,289n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,388 of 28,932 companies
9.5
score / 100
Value
0
Quality
19
FCF yld·
Earn yld-172%
EV/EBITDA·
ROE-158%
Gross mgn36%
Net mgn-48%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Arcadia Biosciences, Inc. is a biotechnology company focused on improving crops for sustainable agriculture. It develops innovative solutions to enhance plant productivity and quality.